Track topics on Twitter Track topics that are important to you
Hemosol BioPharma Inc. is a privately held specialty biopharmaceutical company wholly owned by Catalyst Fund Limited Partnership II. The Company is focused primarily on the development and manufacture of blood related protein based therapeutic products. The Company's activities are focused in the following three areas:
Implementation of the "Cascade" technology for the isolation and purification of plasma proteins. This disruptive technology has the potential to change the business dynamics of the therapeutic plasma proteins sector.
Providing clients with bio-manufacturing and aseptic filling services from the Company's state-of-the-art 130,000 sqft manufacturing facility.
Commercialization of the Company's rich and diverse product Pipeline that encompasses three broad technology platforms, including oxygen therapeutics, drug delivery products and cell therapeutics (growth factors).
In addition to these three core business areas, Hemosol BioPharma Inc. has an active licensing partnership and acquisition program. The company is currently actively seeking partnerships, licensing, and / or product or company acquisition opportunities aimed at complementing its existing operations.
2585 Meadowpine Blvd.
Phone: (905) 286-6200
Fax: (905) 286-6300
Hemosol BioPharma Inc. is a privately held specialty biopharmaceutical company wholly owned by Catalyst Fund Limited Partnership II. The Company is focused primarily on the development and manufactur...
We have published hundreds of Hemasol news stories on BioPortfolio along with dozens of Hemasol Clinical Trials and PubMed Articles about Hemasol for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hemasol Companies in our database. You can also find out about relevant Hemasol Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...